Bay Street News, March 20th, 2025

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that […]

LAS VEGAS, Nevada, March 20, 2025 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today […]

SAN FRANCISCO, March 20, 2025 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable […]

– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid […]

LIBERTY LAKE, Wash., March 20, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for energy […]

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with […]

– Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination […]

WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of […]

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second […]

A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the […]